IP Verse

Oetke, Cornelia opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Oetke, Cornelia

Patent Number:
EP3954778
Title:
Production Of A Mixture Of Neutral Non-Fucosylated Oligosaccharides By A Cell
Applicant:
INBIOSE N.V.
Opposition Date:
Jul 4, 2024
Patent Number:
EP3559230
Title:
Methods For Increasing The Efficiency Of Homology Directed Repair (Hdr) In The Cellular Genome
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Jun 5, 2024
Patent Number:
EP3717631
Title:
Cell Culture Methods
Applicant:
UCB BIOPHARMA SRL
Opposition Date:
May 29, 2024
Patent Number:
EP3597659
Title:
Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides
Applicant:
GENENTECH, INC.
Opposition Date:
Nov 28, 2023
Patent Number:
EP3722434
Title:
Plasmid System
Applicant:
ASCEND GENE AND CELL THERAPIES LTD
Opposition Date:
Apr 27, 2023
Patent Number:
EP3681483
Title:
Process For Lyophilized Pharmaceutical Formulation Of A Therapeutic Protein
Applicant:
AMGEN INC.
Opposition Date:
Feb 20, 2023
Patent Number:
EP3545079
Title:
Controllable Transcription
Applicant:
CAMBRIDGE ENTERPRISE LIMITED
Opposition Date:
Jan 5, 2023
Patent Number:
EP3549611
Title:
Switch Costimulatory Receptors
Applicant:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Opposition Date:
Mar 30, 2022
Patent Number:
EP2970378
Title:
Hydrophobic Interaction Protein Chromatography Under No-Salt Conditions
Applicant:
BIOGEN MA INC.
Opposition Date:
Feb 25, 2022
Patent Number:
EP2997036
Title:
Purification Of Recombinantly Produced Polypeptides
Applicant:
MEDIMMUNE LIMITED
Opposition Date:
Dec 3, 2021

Competitors of Oetke, Cornelia

GENENTECH, INC.

AMGEN INC.

ASCEND GENE AND CELL THERAPIES LTD

Want to track Oetke, Cornelia?

Feel free to send us a message here and we will get back to you